Conjunctival Melanocytic Neoplasia.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
환자: ocular melanocytic tumors
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Uveal melanoma, which is not the topic of this paper, is completely distinct molecular genetically and biologically. Understanding terminology used by ophthalmologists allows for more accurate communication regarding the managment and prognosis of patients with ocular melanocytic tumors.
This article explores pigmented conjunctival lesions, emphasizing their clinical and histopathologic features.
APA
Stagner AM (2026). Conjunctival Melanocytic Neoplasia.. Surgical pathology clinics, 19(1), 63-71. https://doi.org/10.1016/j.path.2025.08.004
MLA
Stagner AM. "Conjunctival Melanocytic Neoplasia.." Surgical pathology clinics, vol. 19, no. 1, 2026, pp. 63-71.
PMID
41651613 ↗
Abstract 한글 요약
This article explores pigmented conjunctival lesions, emphasizing their clinical and histopathologic features. It highlights the diagnostic challenges posed by the overlapping clinical morphologies of benign, premalignant, and malignant melanocytic proliferations; biopsies of such lesions may be evaluated by dermatopathologists. This review discusses the distinct origins and molecular genetics of conjunctival melanocytic neoplasms, especially in sun-exposed areas like the bulbar conjunctiva, which share similarities with their cutaneous counterparts. Uveal melanoma, which is not the topic of this paper, is completely distinct molecular genetically and biologically. Understanding terminology used by ophthalmologists allows for more accurate communication regarding the managment and prognosis of patients with ocular melanocytic tumors.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Therapy-induced androgen receptor signaling as a candidate upstream driver of B7-H3-linked immune exclusion in melanoma: mechanisms and translational opportunities.
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.